If you missed this insightful webinar on Disease modification therapy in MS, please click here to view the video replay.
You can still earn your CPD point from watching the replay. Email John.woodford@newmedia.co.za to let him know that you have watched. For anyone whose CPD governing body is not HPCSA (such as pharmacists), you may request an attendance certificate from John.
Bio
Fellow of the College of Neurologists of South Africa (FC Neurol) by peer review since 2008.
Research: MMed dissertation on Myotonic Dystrophy
Clinical trials: We took part in various clinical trials including: Alnitidan, Aricept, SP511, Lamictin, Elitriptan, Zomitriptan, Topiramate (for migraine prophylaxis), Epilepsy, three Migraine trials, Devco D.
Specific fields of interest
- Multiple Sclerosis
- Parkinson’s Disease
- Dystonia (operates a Botox clinic for dystonia)
- Headache
- Epilepsy
- Peripheral Neurology (Nerve Conductions and EMG)
Publications
Co-author: Giampaolo, D, Bhigjee, A, Retief, C, Isaacs, M, Britz, M, Opperman, D, Govender, R, and van Rensburg, M (2013). Guideline for the diagnosis and management of multiple sclerosis: A Southern African perspective. South African Medical Journal, 103(9), 670-691.
